(Q43686220)

25 November 2017

title

Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program? (English)

1 reference

25 November 2017

0 references

hepatocellular carcinoma

1 reference

Markus Peck-Radosavljevic

inferred from title

author

4

1 reference

25 November 2017

Florian Hucke

1

1 reference

25 November 2017

Wolfgang Sieghart

2

1 reference

25 November 2017

Maximilian Schöniger-Hekele

3

1 reference

25 November 2017

Christian Müller

5

1 reference

25 November 2017

publication date

29 July 2011

1 reference

25 November 2017

published in

Vienna Clinical Weekly

1 reference

25 November 2017

volume

123

1 reference

25 November 2017

issue

17-18

1 reference

25 November 2017

page(s)

542-551

1 reference

https://scigraph.springernature.com/pub.10.1007/s00508-011-0033-9

25 November 2017

exact match

0 references

cites work

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

NF-kappaB signalling: embracing complexity to achieve translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

The changing pattern of epidemiology in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

21 January 2018

A long look at obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Review article: Non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Public health aspects of diabetes mellitus--epidemiology, prevention strategies, policy implications: the first Austrian diabetes report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Hepatocellular carcinoma: comparison of two different periods at the same center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

The surveillance and diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0033-9

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

12 December 2020

[Diabetes and cardiovascular complications]

1 reference

12 December 2020

Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation

1 reference

12 December 2020

Treatment and prognostic factors in patients with hepatocellular carcinoma

1 reference

12 December 2020

Randomized controlled trial of screening for hepatocellular carcinoma

1 reference

12 December 2020

Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

10.1007/S00508-011-0033-9

Identifiers

DOI

1 reference

release_gwvbzp6jkrc2zdy6pytgkajq5a

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gwvbzp6jkrc2zdy6pytgkajq5a

24 November 2022

mapped directly with Wikidata item

1 reference